Endocrine Fibroblast Growth Factors FGF19, FGF21, and FGF23 in Pregnancy and Lactation: Metabolic Regulation and Pregnancy-Related Disorders

Fibroblast growth factors (FGFs) represent a diverse family of proteins that are involved in signaling pathways important for normal development, the maintenance of tissue homeostasis and metabolic regulation. A specific group of endocrine FGFs comprises FGF19, FGF21 and FGF23. These proteins act as offspring. Changes in FGF concentrations are associated with disturbances in glucose and lipid hormones circulating in the blood, regulating bile acid metabolism, energy balance and mineral homeostasis. Pregnancy and lactation are characterized by changes associated with adaptive processes in glucose and lipid metabolism, mineral balance, placental function and maternal energy consumption. This review summarises the molecular mechanisms and physiological functions of endocrine FGFs and discusses their role in maternal adaptation, fetal development and pregnancy-related disorders. Abnormalities in FGF signaling are associated with pre-eclampsia (PE), gestational diabetes mellitus (GDM), intrahepatic cholestasis of pregnancy (ICP), and influence the metabolic regulation of the homeostasis, endothelial and oxidative stress, abnormalities in bile acid and mineral metabolism, placental dysfunction, and fetal metabolic programming. Studies conducted on dairy cows and rodents indicate that FGF21 and FGF23 play a role in lactation-related adaptations, including lipid metabolism, skeletal remodeling, mineral homeostasis and cellular responses to stress. Evidence supporting these functions in lactating women remains limited. Human studies have identified associations between circulating concentrations of the endocrine FGF and pregnancy-related disorders, which support further investigation into their potential as biomarkers. Their clinical relevance, as well as their therapeutic efficacy and safety, remain to be determined.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210436
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Endocrine Fibroblast Growth Factors FGF19, FGF21, and FGF23 in Pregnancy and Lactation: Metabolic Regulation and Pregnancy-Related Disorders

Magdalena Orczyk‐Pawiłowicz, Karolina Baran, Kamila Skrzynska
International Journal of Molecular Sciences
Fibroblast Growth Factor Research
article

Endocrine Fibroblast Growth Factors FGF19, FGF21, and FGF23 in Pregnancy and Lactation: Metabolic Regulation and Pregnancy-Related Disorders

Magdalena Orczyk‐Pawiłowicz, Karolina Baran, Kamila Skrzynska
article en

Abstract

Fibroblast growth factors (FGFs) represent a diverse family of proteins that are involved in signaling pathways important for normal development, the maintenance of tissue homeostasis and metabolic regulation. A specific group of endocrine FGFs comprises FGF19, FGF21 and FGF23. These proteins act as offspring. Changes in FGF concentrations are associated with disturbances in glucose and lipid hormones circulating in the blood, regulating bile acid metabolism, energy balance and mineral homeostasis. Pregnancy and lactation are characterized by changes associated with adaptive processes in glucose and lipid metabolism, mineral balance, placental function and maternal energy consumption. This review summarises the molecular mechanisms and physiological functions of endocrine FGFs and discusses their role in maternal adaptation, fetal development and pregnancy-related disorders. Abnormalities in FGF signaling are associated with pre-eclampsia (PE), gestational diabetes mellitus (GDM), intrahepatic cholestasis of pregnancy (ICP), and influence the metabolic regulation of the homeostasis, endothelial and oxidative stress, abnormalities in bile acid and mineral metabolism, placental dysfunction, and fetal metabolic programming. Studies conducted on dairy cows and rodents indicate that FGF21 and FGF23 play a role in lactation-related adaptations, including lipid metabolism, skeletal remodeling, mineral homeostasis and cellular responses to stress. Evidence supporting these functions in lactating women remains limited. Human studies have identified associations between circulating concentrations of the endocrine FGF and pregnancy-related disorders, which support further investigation into their potential as biomarkers. Their clinical relevance, as well as their therapeutic efficacy and safety, remain to be determined.

International Journal of Molecular SciencesVol. 27(22)
Wroclaw Medical University (PL)
Fibroblast Growth Factor Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon